Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma

被引：0
|
作者：
Bruno, Sabrina
Knight, Andrew David
Wang, Hong
Sander, Cindy
Karapetyan, Lilit
Kirkwood, John M.
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA
[4] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[6] UPMC Hillman Canc Ctr, Melanoma Program, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9589
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Management of melanoma recurrence following adjuvant anti-PD1 therapy
    Owen, C.
    Palmieri, D.
    Guminski, A.
    Carlino, M. S.
    Menzies, A. M.
    Long, G. V.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [3] A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.
    Owen, Carina N.
    Larkin, James M. G.
    Shoushtari, Alexander Noor
    Carlino, Matteo S.
    Blank, Christian U.
    Lee, Belinda
    Mangana, Joanna
    Atkinson, Victoria
    Millward, Michael
    Zaman, Farzana
    Young, Arissa
    Khattak, Muhammad Adnan
    Patel, Sapna Pradyuman
    Hoeller, Christoph
    Hersey, Peter
    Chauhan, Dharmisha
    Palmieri, David James
    Lo, Serigne
    Menzies, Alexander M.
    Long, Georgina V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma
    Nie, Run-Cong
    Yuan, Shu-Qiang
    Wang, Yun
    Chen, Ying-Bo
    Cai, Yan-Yu
    Chen, Shi
    Li, Shu-Man
    Zhou, Jie
    Chen, Guo-Ming
    Luo, Tian-Qi
    Zhou, Zhi-Wei
    Li, Yuan-Fang
    [J]. AGING-US, 2019, 11 (23): : 11576 - 11590
  • [5] Clinical outcomes after adjuvant anti-PD1 therapy for high-risk resectable melanoma and predictors of response
    Marsiglio, John
    Bingjian, Feng
    Kovacsovics, Magdalena
    Gibson, Berit
    Zhou, Qin
    Swami, Umang
    Russell, Jeffery Scott
    Erickson-Wayman, Alyssa
    Asare, Elliot Amponsah
    Monroe, Marcus
    Bowles, Tawnya Lynn
    Nix, David
    Williams, Matthew
    Tan, Aik-choon
    Hyngstrom, John Robert
    Hu-Lieskovan, Siwen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Response to anti-PD1/PDL1 therapy in patients with metastatic desmoplastic melanoma.
    Eroglu, Zeynep
    Kim, Dae Won
    Johnson, Douglas Buckner
    Algazi, Alain Patrick
    Munhoz, Rodrigo Ramella
    Liniker, Elizabeth
    Kong, Ben
    Khurana, Neharika
    Chmielowski, Bartosz
    Sosman, Jeffrey Alan
    Scolyer, Richard A.
    Carlino, Matteo S.
    Postow, Michael Andrew
    Hwu, Wen-Jen
    Long, Georgina V.
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Anti-PD1 antibodies in the adjuvant setting
    Dreno, B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 14 - 14
  • [8] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    [J]. CANCER RESEARCH, 2015, 75
  • [9] PERFORMANCE STATUS AS A PREDICTOR OF RESPONSE TO ANTI-PD1 FOR METASTATIC MELANOMA
    Wong, A.
    Williams, M.
    Milne, D.
    Morris, K.
    Lau, P.
    Spruyt, O.
    Fullerton, S.
    McArthur, G.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 71 - 71
  • [10] Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
    Paoluzzi, L.
    Cacavio, A.
    Ghesani, M.
    Karambelkar, A.
    Rapkiewicz, A.
    Weber, J.
    Rosen, G.
    [J]. CLINICAL SARCOMA RESEARCH, 2016, 6
12345